Article Text

Download PDFPDF

News from EULAR
  1. EULAR Communications

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

EULAR’s new strategy for 2024–2028

European Alliance of Associations for Rheumatology (EULAR) is excited to announce a new and innovative step in its mission to minimise the impact of rheumatic and musculoskeletal diseases (RMDs) on individuals and societies.

EULAR focuses on creating global awareness and providing solutions for the management of RMDs through cutting-edge innovation in research, patient empowerment and expert collaboration.

Read more about EULAR Strategy 2024 - 2028 %7C EULAR

The latest recommendations from EULAR

For recommendations relevant to patient audiences, EULAR provides a lay summary version in English and calls on all interested organisations to disseminate them and encourage the translation into their own language:

Find more EULAR recommendations at EULAR %7C Recommendations and initiatives

EULAR 2024 Annual European Congress of Rheumatology, 12–15 June, in Vienna, Austria

Registration for EULAR 2024 Congress and Abstract Submission is now open! Important note on the Abstract submission deadline — in 2024, it is 15 January.

‘The EULAR 2024 Congress is taking place in the beautiful city of Vienna, Austria, where we will foster knowledge sharing, innovation and striving for excellence through collaboration. Vienna, with its rich history, cultural heritage and warm hospitality, is a perfect location for our Congress.’—Daniel Aletaha, EULAR President.

More details are available at EULAR 2024 – Annual European Congress of Rheumatology.

EULAR’s World Arthritis Day 2023 Campaign

World Arthritis Day (WAD) is a global awareness day, celebrated on 12 October, aimed at increasing knowledge of the existence and impact of RMDs among all audiences.

WAD 2023 aimed to build on last year’s campaign about rheumatology being an invisible specialisation of medicine. To provide more insight, EULAR’s WAD 2023 campaign was focused on highlighting the lifetime journey of a person with an RMD, from being a child and paediatric patient to living with the disease as an adult, including its impact on all aspects of life, like growing-up, working, caring for others or ageing. It also highlighted the role rheumatologists (both paediatric and adult) and diverse healthcare professionals in rheumatology play in lifelong treatment.

Learn more about the campaign World Arthritis Day 2023 %7C EULAR

EULAR research webinars: hands-on insights from experts in the field

The EULAR Research Webinar series provide practical advice to RMD investigators on various topics. Upcoming sessions in the following months will cover EULAR 2024 abstract submissions, research on paediatric RMDs, AI and machine learning in rheumatology and more.

Find out more and register here:

EULAR’s funding programme to support new methodologies in clinical RMD research

The EULAR Research Centre opened a call for applications supporting the development of new methodologies, capabilities and processes in clinical RMD research. The call is open until 15 December 2023. Find out more and apply online:

EULAR school of rheumatology: registration for the upcoming spring and summer courses opens soon

The courses are carefully curated to provide a hands-on learning experience, cutting-edge insights and the latest advancements in rheumatology to elevate your expertise and keep you at the forefront of medical advances.

Learn more and register at

EULAR school of rheumatology offers free registration for Ukrainian Nationals for EULAR Online Courses

To alleviate the hardships experienced by the people of Ukraine and support its scientific community, EULAR is providing free access to all EULAR Online Courses.

All courses are available at EULAR School of Rheumatology.

Ethics statements

Patient consent for publication


  • Handling editor Josef S Smolen

  • Twitter @eular_org

  • Contributors Yuliia Caliskan was responsible for creating and editing content. Stephan Maier was responsible for editing and the overall content as guarantor.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.